This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.00% per year. These returns cover a period from January 1, 1988 through May 4, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
CVS Health Services' Q2 AOI Falls Despite Sales Gain: More Risk Ahead?
by Moumi Mondal
CVS Health's Q2 Health Services revenues climb 10%. Yet, AOI slips as cost pressures and Oak Street's rising MBR ail.
GILD Stock Slips as CVS Health Excludes New HIV Drug Yeztugo
by Zacks Equity Research
Gilead shares slip after CVS refused to add its new HIV drug, Yeztugo, while its Kite unit struck a $350 million deal with Interius BioTherapeutics.
CVS Gains in Pharmacy & Consumer Wellness Despite Reimbursement Woes
by Moumi Mondal
CVS Health's Pharmacy & Consumer Wellness unit posts double-digit revenue gains despite ongoing reimbursement headwinds.
The Zacks Analyst Blog Highlights Health Care Select Sector SPDR, SPDR S&P 500 ETF Trust, UnitedHealth, Regeneron, CVS Health and Novo Nordisk
by Zacks Equity Research
Healthcare stocks trade at a 30-year discount, with XLV showing signs of rebound as Buffett and hedge funds boost exposure.
Zacks.com featured highlights StoneCo, CVS Health, Integer and USANA Health Sciences
by Zacks Equity Research
StoneCo, CVS Health, Integer and USANA Health Sciences stand out as low P/CF value plays with solid growth forecasts in a volatile market.
Is This the Right Time to Consider Healthcare ETFs?
by Sweta Killa
XLV lags SPY by double digits over the past year, but Buffett's UNH bet, hedge fund buys and AI optimism hint at a healthcare revival.
4 Value Stocks Every Investor Should Hold in Volatile Times
by Sumit Singh
StoneCo, CVS, Integer Holdings and USANA emerge as attractive value stocks with low cash-flow ratios and solid growth outlooks.
Value Investing: 5 Undervalued Stocks Worth Adding to Your Portfolio
by Kinjel Shah
StoneCo, CVS Health, KT, KB Financial and USANA Health stand out as undervalued picks with low P/B ratios and solid growth prospects.
Should You Invest in CVS Health (CVS) Based on Bullish Wall Street Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Retail Sales Show Resilience in July: Sector ETFs in Focus
by Sanghamitra Saha
U.S. retail sales rose 0.5% in July, with strength in autos, furniture, online, clothing and health stores driving gains across sectors. One can tap ETFs like ONLN, XRT, IEDI and IHF.